Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23.71 | 25.61 | 31.27 | 26.05 | 27.18 | 26.24 | 28.37 | 23.56 | 25.32 | 26.73 | 31.07 | 24.67 |
| Expenses | 19.28 | 20.70 | 26.54 | 21.62 | 22.05 | 21.70 | 23.60 | 19.81 | 21.82 | 22.95 | 28.64 | 21.35 |
| Operating Profit | 4.43 | 4.91 | 4.73 | 4.43 | 5.13 | 4.54 | 4.77 | 3.75 | 3.50 | 3.78 | 2.43 | 3.32 |
| OPM % | 18.68% | 19.17% | 15.13% | 17.01% | 18.87% | 17.30% | 16.81% | 15.92% | 13.82% | 14.14% | 7.82% | 13.46% |
| Other Income | 1.01 | 1.22 | 0.13 | 0.74 | 0.70 | 0.96 | 0.00 | 0.66 | 0.64 | 1.06 | 1.25 | 0.52 |
| Interest | 0.11 | 0.05 | 0.05 | 0.06 | 0.14 | 0.08 | 0.09 | 0.06 | 0.08 | 0.09 | 0.04 | 0.08 |
| Depreciation | 0.41 | 0.39 | 0.56 | 0.54 | 0.56 | 0.58 | 0.51 | 0.56 | 0.58 | 0.60 | 0.59 | 0.65 |
| Profit before tax | 4.92 | 5.69 | 4.25 | 4.57 | 5.13 | 4.84 | 4.17 | 3.79 | 3.48 | 4.15 | 3.05 | 3.11 |
| Tax % | 25.20% | 25.13% | 34.59% | 24.95% | 26.12% | 24.17% | 23.98% | 25.07% | 25.00% | 11.33% | 43.93% | 25.72% |
| Net Profit | 3.69 | 4.26 | 2.78 | 3.43 | 3.79 | 3.67 | 3.17 | 2.85 | 2.61 | 3.68 | 1.70 | 2.31 |
| EPS in Rs | 3.13 | 3.62 | 2.11 | 2.60 | 2.88 | 2.79 | 2.41 | 2.16 | 1.98 | 2.79 | 1.29 | 1.75 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 40 | 40 | 42 | 48 | 50 | 49 | 69 | 103 | 105 | 107 | 107 | 108 |
| Expenses | 34 | 33 | 35 | 41 | 42 | 41 | 56 | 83 | 86 | 90 | 93 | 95 |
| Operating Profit | 6 | 7 | 7 | 7 | 9 | 9 | 13 | 20 | 19 | 18 | 14 | 13 |
| OPM % | 14% | 17% | 16% | 14% | 17% | 18% | 19% | 19% | 18% | 16% | 13% | 12% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 4 | 3 |
| Interest | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 4 | 5 | 5 | 6 | 7 | 7 | 11 | 19 | 19 | 18 | 14 | 14 |
| Tax % | 27% | 36% | 29% | 29% | 28% | 31% | 27% | 26% | 27% | 24% | 25% | |
| Net Profit | 3 | 3 | 4 | 4 | 5 | 5 | 8 | 14 | 14 | 14 | 11 | 10 |
| EPS in Rs | 3.04 | 3.21 | 3.67 | 4.04 | 5.29 | 5.01 | 8.33 | 11.94 | 10.71 | 10.47 | 8.22 | 7.81 |
| Dividend Payout % | 17% | 16% | 14% | 12% | 0% | 20% | 18% | 7% | 7% | 8% | 39% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 10% | 17% | 1% | 2% | ||
| Compounded Profit Growth | 14% | 17% | -8% | -24% | ||
| Stock Price CAGR | 8% | 14% | -17% | -24% | ||
| Return on Equity | 13% | 12% | 10% | 8% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 10 | 12 | 13 | 13 | 13 |
| Reserves | 13 | 16 | 19 | 22 | 25 | 30 | 35 | 37 | 84 | 112 | 121 | 128 |
| Borrowings | 7 | 5 | 7 | 6 | 5 | 4 | 4 | 4 | 6 | 6 | 5 | 6 |
| Other Liabilities | 8 | 11 | 9 | 12 | 9 | 12 | 14 | 22 | 21 | 28 | 24 | 25 |
| Total Liabilities | 33 | 37 | 39 | 44 | 44 | 52 | 58 | 74 | 123 | 159 | 163 | 172 |
| Fixed Assets | 7 | 7 | 8 | 7 | 7 | 6 | 7 | 7 | 8 | 14 | 18 | 20 |
| CWIP | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 6 | 15 | 17 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 |
| Other Assets | 26 | 28 | 30 | 36 | 36 | 44 | 49 | 65 | 111 | 137 | 131 | 135 |
| Total Assets | 33 | 37 | 39 | 44 | 44 | 52 | 58 | 74 | 123 | 159 | 163 | 172 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 1 | 3 | 1 | 3 | 2 | 5 | 5 | -2 | 0 | 10 | 4 | 10 |
| Cash from Investing Activity | -1 | -2 | -2 | -1 | -1 | -2 | -1 | -0 | -34 | -7 | -16 | -7 |
| Cash from Financing Activity | 0 | -1 | 1 | -2 | -2 | -1 | -2 | -1 | 36 | 16 | -5 | -4 |
| Net Cash Flow | 0 | -1 | 0 | -0 | 0 | 1 | 3 | -2 | 1 | 18 | -18 | -1 |
| Free Cash Flow | -0 | -0 | -1 | 2 | 1 | 4 | 3 | -3 | -4 | -0 | -12 | 3 |
| CFO/OP | 46% | 69% | 45% | 79% | 63% | 73% | 85% | 5% | 28% | 82% | 48% | 103% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 142 | 134 | 138 | 170 | 137 | 164 | 140 | 172 | 137 | 137 | 119 | 134 |
| Inventory Days | 154 | 155 | 185 | 185 | 164 | 186 | 246 | 237 | 181 | 211 | 246 | 230 |
| Days Payable | 80 | 109 | 83 | 124 | 73 | 111 | 152 | 158 | 89 | 114 | 88 | 90 |
| Cash Conversion Cycle | 216 | 181 | 240 | 231 | 229 | 239 | 235 | 251 | 230 | 234 | 276 | 274 |
| Working Capital Days | 136 | 138 | 137 | 150 | 155 | 170 | 167 | 192 | 173 | 178 | 204 | 203 |
| ROCE % | 14% | 19% | 20% | 18% | 18% | 20% | 19% | 25% | 26% | 17% | 14% | 10% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 58.08% | 58.08% | 58.08% | 56.12% | 56.12% | 56.12% | 56.12% | 56.12% | 56.12% | 56.12% | 56.12% | 56.12% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 1.14% | 1.14% | 0.98% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 41.92% | 41.93% | 41.92% | 43.87% | 42.74% | 42.74% | 42.89% | 43.87% | 43.87% | 43.89% | 43.89% | 43.88% |
| No. of Shareholders | 6,794 | 8,073 | 8,140 | 7,960 | 7,854 | 8,092 | 8,248 | 8,344 | 8,783 | 8,364 | 8,099 | 7,966 |
Fundamentals
Market Cap₹ 138 Cr.
Current Price₹ 105
Stock P/E13.4
Book Value₹ 107
ROCE10.3 %
ROE7.89 %
Dividend Yield3.06 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)2%
Compounded Profit Growth (TTM)-24%
Standalone figures.
Valuation
Market capRs 135 Cr
Enterprise valueRs 137 Cr
P/E (TTM)13.15x
Price to book0.96x
Price to sales1.26x
EV / EBITDA8.32x
EV / EBIT9.75x
EV / sales1.27x
Price to cash flow13.14x
Earnings yield7.60%
Dividend yield3.11%
P/E, 3-year average14.03x
P/B, 3-year average1.41x
P/E, 5-year average14.99x
P/B, 5-year average1.92x
Profitability
Operating margin (excl. other income)12.70%
Operating margin (incl. other income)16.00%
EBITDA margin15.31%
Pre-tax margin12.79%
Net profit margin9.56%
Net margin, latest quarter9.36%
ROE7.89%
ROCE10.32%
ROA6.46%
ROE, 3-year average10.43%
ROCE, 3-year average13.61%
ROA, 3-year average8.34%
ROE, 5-year average14.02%
ROCE, 5-year average18.21%
ROA, 5-year average10.41%
ROIC (approx.)7.39%
Tax rate25.16%
Other income / net worth2.50%
Growth
Sales growth (latest year)-0.37%
Profit growth (latest year)-21.46%
Sales CAGR, 3 years1.15%
Sales CAGR, 5 years16.63%
Profit CAGR, 3 years-8.35%
Profit CAGR, 5 years16.67%
Sales growth QoQ-20.60%
Profit growth QoQ35.88%
Sales growth YoY (latest quarter)4.71%
Profit growth YoY (latest quarter)-18.95%
Per share
EPS (TTM)Rs 7.82
EPS (latest year)Rs 8.22
EPS (latest quarter)Rs 1.75
EPS, 3-year averageRs 9.80
EPS, 5-year averageRs 9.94
Book value per shareRs 106.92
Sales per shareRs 81.83
Cash flow per shareRs 7.83
Free cash flow per shareRs 2.28
Dividend per share (latest year)Rs 3.20
Dividend per share, 3-year averageRs 1.60
Dividend per share, 5-year averageRs 1.42
Dividends
Dividend payout38.87%
Dividend payout, 3-year average17.98%
Dividend payout, 5-year average15.71%
Efficiency
Asset turnover0.62x
Fixed asset turnover5.29x
Inventory turnover1.78x
Inventory days204 days
Debtor days134 days
Debtors turnover2.72x
Creditor days90 days
Cash conversion cycle274 days
Working capital days203 days
Leverage
Total debtRs 6 Cr
Cash and bankRs 4 Cr
Net debtRs 2 Cr
Debt to equity0.04x
Net debt / EBITDA0.11x
Interest coverage48.55x
Owners' fund to total sources81.91%
Debt to assets3.28%
Cash flow
Cash from Operating Activity (latest year)Rs 10 Cr
Cash from Investing Activity (latest year)Rs -7 Cr
Cash from Financing Activity (latest year)Rs -4 Cr
Net Cash Flow (latest year)Rs -1 Cr
Free cash flow (latest year)Rs 3 Cr
FCFE (approx.: FCF + change in debt)Rs 3 Cr
Cash from ops / profit, 5 years0.36x
Sales to cash flow10.36x
Statement figures
Net sales (TTM)Rs 108 Cr
Net sales (latest year)Rs 107 Cr
Sales (latest quarter)Rs 25 Cr
Operating profit excl. other income (latest year)Rs 14 Cr
Operating profit (latest quarter)Rs 3 Cr
Other income (TTM)Rs 3 Cr
EBITDA (TTM)Rs 16 Cr
PBDT (TTM)Rs 16 Cr
Profit before tax (TTM)Rs 14 Cr
Tax (latest year)Rs 4 Cr
Net profit (TTM)Rs 10 Cr
Net profit (latest year)Rs 11 Cr
Net profit (latest quarter)Rs 2 Cr
Depreciation (TTM)Rs 2 Cr
Depreciation (latest quarter)Rs 1 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 80 Cr
Total expenditure (latest year)Rs 93 Cr
Total income (latest year)Rs 110 Cr
Share capitalRs 13 Cr
ReservesRs 128 Cr
Shareholders' fundsRs 141 Cr
Total assetsRs 172 Cr
Net blockRs 20 Cr
Capital work in progressRs 17 Cr
ReceivablesRs 39 Cr
InventoryRs 45 Cr
Other liabilitiesRs 25 Cr
Shares outstanding (crore)1.32
Ownership
Promoter holding56.12% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 13.2 is at the 37th percentile of its own 9.4-year range
(median 14.7, low 5.9, high 58.0).
P/B 0.96 is at the 2th percentile (median 1.69).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 531726 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -3.6% | -2.8% | -0.8 pts |
| 1 month | -13.2% | -6.8% | -6.4 pts |
| 3 months | -12.8% | -7.6% | -5.2 pts |
| 3 years | -43.1% | +14.2% | -57.3 pts |
| 5 years | +88.1% | +27.9% | +60.2 pts |
Red flags
F-score 4 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹25 Cr +4.7% vs Jun 2025.
Net profit ₹2 Cr -18.9%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Panchsheel Organics Ltd?
Panchsheel Organics Ltd (531726) has a market capitalisation of Rs 138 Cr. at the 2026-10-01 close.
What is the P/E ratio of Panchsheel Organics Ltd?
Panchsheel Organics Ltd trades at a P/E of 13.4 on trailing twelve-month profit, at the 2026-10-01 close.
What were Panchsheel Organics Ltd's latest quarterly results?
In the Jun 2026 quarter, Panchsheel Organics Ltd sales was Rs 25 Cr (+4.7% vs Jun 2025) and net profit was Rs 2 Cr.